Recent News From BriaCell Points To Meaningful Progress
VBI's Sci-B-Vac Should Take Market Share In The Hepatitis B Vaccine Market
MabVax Phase 1 Trial With HuMab-5B1 Progressing Nicely
Immune Forms Pain & Neurology Spin-Off Called Maxim Pharma
Actinium Pharmaceuticals: Well Positioned For A Breakout 2017
Exactus' FibriLyzer Device Solves A Big Problem For Surgical Patients
HedgePath Pharma Has Nice Upside As SUBA-Itraconazole Development Continues
RedHill's Pipeline Offers Significant Value For Investors
MabVax Looks Very Interesting Ahead Of Data Later This Month
What's Next For BrainStorm Cell Therapeutics